See how Create SD Holdings' latest quarter compares with other retailers balancing sales momentum against thinner earnings in our curated set of 15 high quality undervalued stocks.
Create SD Holdings asks you to believe in a fairly straightforward story. A broad drugstore and prescription footprint in Japan, steady consumer demand for daily necessities and healthcare items, and an operating model that can convert that traffic into consistent earnings over time. The latest quarter fits that picture only partially. Sales moved to ¥129,540 million while net income softened to ¥3,788 million, and earnings per share from continuing operations slipped to ¥58.64. That mix reinforces the idea that execution and cost discipline matter as much as store count or ticket size.
In the short term, the key swing factors are pricing power in core categories, expense control in a still competitive retail market, and how much capital needs to go into new locations or care facilities to keep revenue moving. The slight net margin pressure mirrors earlier data that profit growth has slowed to 3.2% over the past year compared with a 5 year pace of 7.8%. A P/E of 12.3x below both the JP market and Consumer Retailing averages suggests expectations are not stretched. At the same time, the weaker first quarter earnings keep the focus on whether Create SD Holdings can defend profitability while still investing in growth projects.
Even so, there is a less comfortable angle once you factor in ...
There's only one way to know the right time to buy, sell or hold Create SD Holdings. Head to Simply Wall St's company report for the latest analysis of Create SD Holdings's Fair Value.
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so consider your own judgment carefully.
If the Create SD Holdings update has you rethinking where new capital should go, it can help to scan a broader set of opportunities using structured filters rather than gut feel alone.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com